RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)
The combination of Irinotecan Hydrochloride (IRI) and Capecitabine (CAP) is indicated for the treatment of cancer. IRI and CAP were developed by an simultaneous simple reverse phase liquid chromatographic method and were subsequently validated from their APIs. The proposed method was based upon the...
Saved in:
Published in | International journal of research in pharmaceutical sciences Vol. 9; no. 1; p. 63 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
12.03.2018
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!